C reactive protein levels are increased in non-allergic but not allergic asthma: A multicentre epidemiological study

Thorax

Volumn 60, Issue 6, 2005, Pages 451-454

  Olafsdottir I S ^a   Gislason, T ^a   Thjodleifsson, B ^a   Olafsson, I ^a   Gislason, D ^a   Jogi R ^b   Janson, C ^c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; ATOPY; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SMOKING; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; ASTHMA; BODY MASS INDEX; BRONCHIAL HYPERREACTIVITY; C-REACTIVE PROTEIN; DYSPNEA; FEMALE; HUMANS; MALE; RESPIRATION DISORDERS; SMOKING;

EID: 20444485838     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.035774     Document Type: Article

References (29)

1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
2. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7.
3. Wilkins J, Gallimore JR, Moore EG, et al. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998;44:1358-61.
4. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8.
5. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5.
6. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003;40:733-9.
7. Jousilahti P, Salomaa V, Hakala K, et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89:381-5.
8. Cirilla DJ, Agrawal Y, Cassano PA. Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;155:842-8.
9. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
10. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003;114:758-62.
11. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80.
12. Kony S, Zureik M, Driss F, et al. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004;59:892-6.
13. Jarvis D, Chinn S, Potts J, et al. Association of body mass index with respiratory symptoms and atopy: results from the European Community Respiratory Health Survey. Clin Exp Allergy 2002;32:831-7.
14. Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 2002;121:158-63.
15. Gunnbjornsdottir MI, Omenaas E, Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004;24:116-21.
16. Janson C, Chinn S, Jarvis D, et al. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997;10:1795-802.
17. Chinn S, Burney P, Jarvis D, et al. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997;10:2495-501.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
19. Chen Y, Dales R, Tang M, et al. Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the Canadian National Population Health Surveys. Am J Epidemiol 2002;155:191-7.
20. Beckett WS, Jacobs DR Jr, Yu X, et al. Asthma is associated with weight gain in females but not males, independent of physical activity. Am J Respir Crit Care Med 2001;164:2045-50.
21. Schachter LM, Salome CM, Peat JK, et al. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001;56:4-8.
22. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002;162:1477-81.
23. Richter JE. Gastroesophageal reflux disease and asthma: the two are directly related. Am J Med 2000;108(Suppl 4a):153-85.
24. Stenius-Aarniala B, Poussa T, Kvarnstrom J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000;320:827-32.
25. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000;118:1315-21.
26. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004;27:1699-705.
27. Ludviksdottir D, Janson C, Bjornsson E, et al. Different airway responsiveness profiles in atopic asthma, nonotopic asthma, and Sjogren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 2000;55:259-65.
28. Ludviksdottir D, Janson C, Hogman M, et al. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR Group. Respir Med 1999;93:552-6.
29. Amin K, Ludviksdottir D, Jonson C, et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000;162:2295-301.